![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 04, 2020 12:38:52 PM
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance
WE ARE NOT A SEROLOGY TEST. BUT THE FDA, 95% THRESHOLD REQUIREMENT FOR ANTIBODY CAN ONLY INDICATE VIRAL INFECTION, BY DETECTABLE ANTIBODIES THROUGH BLOOD SERUM CONVERSION - - “SEROCONVERSION.”
Viral infection or Virus must be present BEFORE DETECTABLE ANTIBODY LEVEL PRODUCTION. Rather than testing for antibodies, the GENVIRO SWIFT can detect the present virus in the early stage, BEFORE ANTIBODY PRODUCTION - - SEROCONVERSION.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM